Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia. (Q40708171)
Jump to navigation
Jump to search
scientific article published on 17 May 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia. |
scientific article published on 17 May 2016 |
Statements
Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia (English)
Julio C Chavez
Miguel Piris-Villaespesa
Samir Dalia
Elyce Turba
Lisa Nodzon
Rami Komrokji
Lubomir Sokol
Frederick L Locke
Jeffrey Lancet
Eduardo M Sotomayor
Mohamed A Kharfan-Dabaja
Javier Pinilla-Ibarz